Obesity: Pathogenesis and emerging targets for drug development


Amit Gupta

Abstract


Obesity leads to premature death and impairs quality of life. In general, weight loss is responsible and reduced the risk of cardiovascular disease that is associated with obesity. One of the recognized and well establishment treatment option for weight loss i.e. pharmacotherapy where cardiovascular safety issues with some previous weight loss drugs raise concerns for newly approved pharmacotherapies. Previously, number of anti-obesity drugs that are already withdrawn from the market because of adverse side effects. In the present study, our group focused only on antiobesity drugs that are currently under investigation and also understand its pathogenesis.  Although lot of anti-obesity drugs are in the pipeline, the process for getting such type of drugs to be marketed has recently proven so difficult.


| PDF |


About this article

Title

Obesity: Pathogenesis and emerging targets for drug development

Date

01-01-2017

Additional Links

Manuscript Submission

Journal

Innovare Journal of Health Sciences
Vol 5 Issue 1 2017 (January-February) Page: 6-9

Online ISSN

2347-5536

Statistics

72 Views | 68 Downloads

Authors & Affiliations

Amit Gupta
Vidya Pratishthan School of Biotechnology
India


Refbacks

  • There are currently no refbacks.